Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma.

This publication has 4 references indexed in Scilit:

• REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENT
  The Lancet, 1987
• Effects of Transforming Growth Factor-β on Osteoblastic Osteosarcoma Cells*
  Endocrinology, 1987
• Value of CA 15:3 in the follow-up of breast cancer patients
  British Journal of Cancer, 1987
• Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro.
  Proceedings of the National Academy of Sciences, 1986